Global Bone Substitutes and Bone Allografts Market
Bone Substitutes and Bone Allografts Market Report Description:
Bone substitutes and bone allografts market report gives comprehensive outlook on bone substitutes and bone allografts across the countries such as Japan, Brazil, India, Australia & New Zealand, and China. The report on bone substitutes and bone allografts market gives historical, current, and future market sizes (US$ Mn) on the basis of product type and country. This report studies bone substitutes and bone allografts market dynamics elaborately to identify the current market trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, bone substitutes and bone allografts market report includes regulatory scenario, and products analysis with vividly illustrated the product dashboard to assess the market competition. Moreover, PBI analyzed bone substitutes and bone allografts market to better equip clients with possible investment opportunities across the countries (Country Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the bone substitutes and bone allografts market report include suppliers, manufacturers, marketers, policy makers, and healthcare service providers engaged in bone substitutes and bone allografts usage or advocacy.
Bone Substitutes and Bone Allografts Market:
The Japan bone substitutes and bone allografts market estimated to be valued US$ 216.5 Mn in 2017 and poised to grow at significant CAGR over 2018-2024 due to surge in aging population, increase in prevalence of bones and joint fractures, and product launchings by the market players in the country.
Increase in the prevalence of arthritis
Increase in the prevalence of arthritis coupled with surge in number of geriatric population around the globe expected to fuel the market for bone substitutes and bone allografts over the forecast period. As per the World Health Organization (WHO), more than 2 Bn global population will be over the age of 60 by the year 2050. Rise in geriatric population in developed nation such as Japan, expected to drive the market over the forecast years.
Technological advancements in the bone substitutes and bone grafts
Bone graft substitutes play an important role in dental surgery/implantology in order to assure optimal management of the patient. Technological advancements in the bone substitutes and bone grafts surge the market over the forecast years. For instance, in June 2017, Bonesupport, a Swedish firm developed injectable bioceramic bone substitute products to treat bone voids caused by trauma, infection, disease or related surgery.
Japan Accounts for Larger Market Revenue Share in Bone Substitutes and Bone Allografts Market
Japan accounted for larger revenue share in bone substitutes and bone allografts market with moderate CAGR. Increase in the adoption of bone substitutes and bone allograft procedures, rise in geriatric population, and increase R&D activities for the development of newer products are expected to drive the market. China market projected to exhibit significant growth owing to increase in the prevalence of bone disorders such as osteoporosis For instance, According to International Osteoporosis Foundation, approximately 7% among adults, 10-20% in urban areas, 22.5% among men aged 50 years or more, and 50.1% among women aged 50 years or more are affected to osteoporosis in China
Competition Assessment
Key players profiled in the bone substitutes and bone allografts market include:
- Medtronic (U.S)
- Stryker Corporation (U.S)
- Smith and Nephew Inc. (U.S)
- NuVasive, Inc. (U.S)
- Wright Medical Group N.V (U.S)
- Zimmer Biomet (U.S.)
- Biocomposites, Inc. (U.S.)
- Baumer S.A. (Brazil)
Bone substitutes and bone allografts market is driven by launch and approval of products by the market players. For instance, In March 2018, Synergy Biomedical, LLC received Therapeutic Goods Administration (TGA) clearance in Australia for its bioactive bone graft, Biosphere Putty, an advanced synthetic bone graft product that has previously received FDA and CE Mark clearance
.
Key Findings of the Report:
- Bone Substitutes and Bone Allografts market expanding at significant CAGR over 2018 to 2024 owing to increase in the prevalence of bone and joint fractures around
- Based on product type, bone substitutes segment accounted for larger market revenue share in 2017 and projected gain market revenue share over the forecast period
- Players focusing on innovation of newer products and collaboration strategies to retain market position in global bone substitutes and bone allografts market
Key Features of the Report:
- The report provides granular level information about the market size, regional market share, historic market (2016-2017) and forecast (2018-2024)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startup’s details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Detailed Segmentation
By Product Type
- Bone Substitutes
- Hydroxyapatites (HAp)
- Calcium Phosphate
- Calcium Sulphate
- Bioactive Glass
- Bone Allografts
- Freeze Dried
- Demineralized Bone Matrix
Geography
- Japan
- Brazil
- India
- Australia 7 new Zealand
- China
Press Releases:
https://www.precisionbusinessinsights.com/press-release/bone-substitutes-bone-allografts-market/
